Household COVID-19 risk and in-person schooling.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
    • Publication Information:
      Publication: : Washington, DC : American Association for the Advancement of Science
      Original Publication: New York, N.Y. : [s.n.] 1880-
    • Subject Terms:
    • Abstract:
      In-person schooling has proved contentious and difficult to study throughout the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Data from a massive online survey in the United States indicate an increased risk of COVID-19-related outcomes among respondents living with a child attending school in person. School-based mitigation measures are associated with significant reductions in risk, particularly daily symptoms screens, teacher masking, and closure of extracurricular activities. A positive association between in-person schooling and COVID-19 outcomes persists at low levels of mitigation, but when seven or more mitigation measures are reported, a significant relationship is no longer observed. Among teachers, working outside the home was associated with an increase in COVID-19-related outcomes, but this association is similar to that observed in other occupations (e.g., health care or office work). Although in-person schooling is associated with household COVID-19 risk, this risk can likely be controlled with properly implemented school-based mitigation measures.
      (Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
    • References:
      Lancet Infect Dis. 2021 Mar;21(3):344-353. (PMID: 33306981)
      Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):. (PMID: 33574041)
      J Res Educ Eff. 2023;16(3):419-441. (PMID: 37605777)
      Euro Surveill. 2020 Jul;25(29):. (PMID: 32720636)
      MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025. (PMID: 32759921)
      MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1319-1323. (PMID: 32941418)
      Lancet Infect Dis. 2021 Feb;21(2):193-202. (PMID: 33729915)
      MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):136-140. (PMID: 33507890)
      N Engl J Med. 2021 Feb 18;384(7):669-671. (PMID: 33406327)
      Lancet Infect Dis. 2021 Mar;21(3):298-299. (PMID: 33306982)
      Nature. 2020 Aug;584(7820):257-261. (PMID: 32512579)
      Science. 2020 Jun 26;368(6498):1481-1486. (PMID: 32350060)
      JAMA Pediatr. 2021 Feb 1;175(2):143-156. (PMID: 32975552)
      Lancet Infect Dis. 2020 May;20(5):533-534. (PMID: 32087114)
    • Grant Information:
      K01 AI125086 United States AI NIAID NIH HHS; T32 AG000247 United States AG NIA NIH HHS
    • Publication Date:
      Date Created: 20210430 Date Completed: 20210611 Latest Revision: 20240830
    • Publication Date:
      20240830
    • Accession Number:
      PMC8168618
    • Accession Number:
      10.1126/science.abh2939
    • Accession Number:
      33927057